US Patent Litigations are now available. Check here

In the competitive field of Form Specific Drugs, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Form Specific Drugs technology and learn how to protect your intellectual property.

Get Comprehensive Patent Opposition Report for the Form Specific Drugs Industry

Gain strategic insights, uncover critical details, and make informed decisions with expert-backed analysis.

Get Your Report Now

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Form Specific Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Form Specific Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jun 12, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Form Specific Drugs industry

EP3641727Cannabinoid PouchMEDCAN PHARMAMay 7, 2025NICOVENTURES
EP3801459Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMay 7, 2025SYNTHON
EP3781210Treatment Of Sepsis And Septic ShockCOMBIOXINMay 6, 2025BRAND MURRAY FULLER
EP3801459Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMay 6, 2025SANDOZ
EP4241767Novel Lipids And Compositions For The Delivery Of TherapeuticsARBUTUS BIOPHARMAApr 29, 2025MODERNATX
EP4284387Nad-Augmentation Therapy For Parkinson'S DiseaseVESTLANDETS INNOVASJONSSELSKAP VISApr 29, 2025IMMUNOPHARMA
EP2854831Manufacture Of DegarelixFERRINGApr 10, 2025ZIMMERMANN & PARTNER PATENTANWALTE MBB
EP2818163Composition For Nasal Application With Improved StabilityMARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFTMar 26, 2025KRKA
EP2854831Manufacture Of DegarelixFERRINGMar 24, 2025KRAUS & LEDERER PARTGMBB
EP2818163Composition For Nasal Application With Improved StabilityMARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFTMar 20, 2025HAMM&WITTKOPP PATENTANWALTE PARTMBB

To stay ahead in the competitive Form Specific Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Form Specific Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jun 12, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2395968Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM18
EP3246021Nov 13, 2019Apixaban FormulationsBRISTOL MYERS SQUIBB IRELAND UNLIMITED12
EP2425821May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneMUNDIPHARMA11
EP2425824May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneMUNDIPHARMA11
EP3395339Dec 11, 2019Rapid Dissolution Formulation Of A Cinacalcet HclAMGEN11
EP3725778Aug 18, 2021Formulations Of EnzalutamideMEDIVATION PROSTATE THERAPEUTICS11
EP3251660Oct 16, 2019Apixaban FormulationsBRISTOL MYERS SQUIBB IRELAND10
EP2228064Dec 11, 2019Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor AgonistNOVARTIS10
EP3260117Nov 27, 2019Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGEN10
EP2791160Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNA THERAPEUTICS10